262 related articles for article (PubMed ID: 11545286)
1. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
2. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
Salva A; Hardy MP; Wu XF; Sottas CM; MacLaughlin DT; Donahoe PK; Lee MM
Biol Reprod; 2004 Mar; 70(3):600-7. PubMed ID: 14585814
[TBL] [Abstract][Full Text] [Related]
3. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
Wu X; Arumugam R; Baker SP; Lee MM
Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
[TBL] [Abstract][Full Text] [Related]
4. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
Trbovich AM; Sluss PM; Laurich VM; O'Neill FH; MacLaughlin DT; Donahoe PK; Teixeira J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3393-7. PubMed ID: 11248089
[TBL] [Abstract][Full Text] [Related]
5. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
6. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
7. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
8. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
9. Effects of vitamins C and E on steroidogenic enzymes mRNA expression in polychlorinated biphenyl (Aroclor 1254) exposed adult rat Leydig cells.
Murugesan P; Muthusamy T; Balasubramanian K; Arunakaran J
Toxicology; 2007 Apr; 232(3):170-82. PubMed ID: 17280759
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of intrauterine exposure to mono-n-butyl phthalate on the reproductive function of postnatal rats.
Kai H; Shono T; Tajiri T; Suita S
J Pediatr Surg; 2005 Feb; 40(2):429-33. PubMed ID: 15750943
[TBL] [Abstract][Full Text] [Related]
11. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse.
Al-Attar L; Noël K; Dutertre M; Belville C; Forest MG; Burgoyne PS; Josso N; Rey R
J Clin Invest; 1997 Sep; 100(6):1335-43. PubMed ID: 9294098
[TBL] [Abstract][Full Text] [Related]
13. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
[TBL] [Abstract][Full Text] [Related]
14. Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation.
Nagai A; Ikeda Y; Aso T; Eto K; Ikeda MA
J Med Dent Sci; 2003 Mar; 50(1):35-40. PubMed ID: 12715917
[TBL] [Abstract][Full Text] [Related]
15. [Ginkgo biloba extract enhances testosterone synthesis of Leydig cells in type 2 diabetic rats].
Wu XY; Wang WY; Wang RR; Xie L; Fang ZX; Chen GR
Zhonghua Nan Ke Xue; 2008 Apr; 14(4):371-6. PubMed ID: 18481435
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
[TBL] [Abstract][Full Text] [Related]
17. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
18. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Laurich VM; Trbovich AM; O'Neill FH; Houk CP; Sluss PM; Payne AH; Donahoe PK; Teixeira J
Endocrinology; 2002 Sep; 143(9):3351-60. PubMed ID: 12193547
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific fetal lung development and müllerian inhibiting substance.
Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
[TBL] [Abstract][Full Text] [Related]
20. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]